Condition: Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Sponsor: BeOne Medicines
The purpose of this study is to evaluate the efficacy and safety of BGB-16673 alone compared with pirtobrutinib in patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who had been previously treated with a covalent Bruton tyrosine kinase inhibitor (cBTKi).
This description comes directly from the study's public registry record.
Study Director · 1-877-828-5568 · clinicaltrials@beonemed.com
Always discuss trial participation with your own doctor first.
| University of Alabama At Birmingham Hospital | Birmingham, Alabama, United States | Recruiting |
| Mayo Clinic Phoenix | Phoenix, Arizona, United States | Recruiting |
| Kaiser Permanente Southern California | Irvine, California, United States | Recruiting |
| University of California San Diego (Ucsd) Moores Cancer Center | La Jolla, California, United States | Recruiting |
| Cancer and Blood Specialty Clinic | Los Alamitos, California, United States | Recruiting |
| UCLA Department of Medicine Hematologyoncology | Los Angeles, California, United States | Recruiting |
| Stanford Cancer Institute | Palo Alto, California, United States | Recruiting |
| Kaiser Permanente Roseville Medical Center | Roseville, California, United States | Recruiting |
| Kaiser Permanente Northern California | Vallejo, California, United States | Recruiting |
| Kaiser Permanente Walnut Creek Medical Center | Walnut Creek, California, United States | Recruiting |
| Christiana Care | Newark, Delaware, United States | Recruiting |
| Medstar Georgetown University Hospital | Washington D.C., District of Columbia, United States | Recruiting |
+ 185 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06973187